(Q27641682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Gennaro Ciliberto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Elisabetta Bianchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Paolo Ingallinella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

William H Hurni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Michael D Miller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Riccardo Cortese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Renzo Bazzo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

John W Shiver

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Antonello Pessi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Biology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1101-1115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of viral membrane fusion and its inhibition

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Peptides and membrane fusion: towards an understanding of the molecular mechanism of protein-induced fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Atomic structure of the ectodomain from HIV-1 gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

HIV entry and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Multiepitope vaccines intensively increased levels of antibodies recognizing three neutralizing epitopes on human immunodeficiency virus-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Core structure of gp41 from the HIV envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Atomic structure of a thermostable subdomain of HIV-1 gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A general model for the transmembrane proteins of HIV and other retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A self-consistent method for the analysis of protein secondary structure from circular dichroism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Multi-conformational peptide dynamics derived from NMR data: A new search algorithm and its application to antamanide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Trimeric Subdomain of the Simian Immunodeficiency Virus Envelope Glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Beta-hairpins in proteins revisited: lessons for de novo design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

NMRPipe: a multidimensional spectral processing system based on UNIX pipes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

NMR View: A computer program for the visualization and analysis of NMR data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

The solution structure of a specific GAGA factor-DNA complex reveals a modular binding mode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

7 January 2021

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

7 January 2021

Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

7 January 2021

A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900611-9

7 January 2021

10.1016/S0022-2836(03)00611-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12860131%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference